While the combination of pembrolizumab with standard-of-care (SOC) radiation, and androgen deprivation therapy (ADT) with or ...

Claire Conley, PhD, and Marcelo Sleiman, Jr., discuss the need for protocols in supporting patients’ psychosocial needs.

The Oncology Nursing Society (ONS) is developing a skin of color toxicity photo repository with funding from a grant from La ...

Zongertinib has been granted accelerated approval in NSCLC harboring HER2 TKD mutations as part of the Commissioner’s ...

Neoadjuvant EV plus pembrolizumab significantly improved event-free survival and overall survival vs gemcitabine/cisplatin in the phase 3 KEYNOTE-B15 trial. Neoadjuvant and adjuvant enfortumab vedotin ...

The FDA has approved a monthly dosing schedule for subcutaneous amivantamab in NSCLC following the first 4 weeks of treatment ...

Treatment with systemic intravenous olvimulogene nanivacirepvec (Olvi-Vec) led to promising preliminary results in patients with progressive non–small cell lung cancer (NSCLC) and progressive SCLC ...

AI in oncology nursing remains in its early stages, but it’s already reshaping health care. This moment was evident at the 2025 American Society of Hematology Annual Meeting and Exposition, which ...

The FDA has approved encorafenib plus cetuximab and fluorouracil-based chemotherapy in patients with BRAF V600E-positive metastatic colorectal cancer. The FDA has approved encorafenib (Braftovi) ...

The FDA has approved acalabrutinib plus venetoclax in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. The FDA has approved the use of acalabrutinib (Calquence) tablets ...

Welcome to Onc Nurse On Call, the new podcast from Oncology Nursing News, hosted by editors-in-chief Patricia Jakel, MN, RN, ...